Detalhe da pesquisa
1.
Identification of HGD and GSTZ1 as Biomarkers Involved Metabolic Reprogramming in Kidney Renal Clear Cell Carcinoma.
Int J Mol Sci
; 23(9)2022 Apr 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35562974
2.
PIKE-A Modulates Mitochondrial Metabolism through Increasing SDHA Expression Mediated by STAT3/FTO Axis.
Int J Mol Sci
; 23(19)2022 Sep 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36232604
3.
Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression.
J Exp Clin Cancer Res
; 43(1): 108, 2024 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38600610
4.
PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1.
MedComm (2020)
; 4(2): e245, 2023 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-36999124
5.
PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism.
Acta Pharm Sin B
; 13(1): 157-173, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36815049
6.
Decreased SLC27A5 Suppresses Lipid Synthesis and Tyrosine Metabolism to Activate the Cell Cycle in Hepatocellular Carcinoma.
Biomedicines
; 10(2)2022 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35203444
7.
The Potential Mechanisms of Cinobufotalin Treating Colon Adenocarcinoma by Network Pharmacology.
Front Pharmacol
; 13: 934729, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35814224
8.
PRIM2 Promotes Cell Cycle and Tumor Progression in p53-Mutant Lung Cancer.
Cancers (Basel)
; 14(14)2022 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35884433
9.
Correction: Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/ GPX4 expression.
J Exp Clin Cancer Res
; 43(1): 131, 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38693552
10.
FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1.
Clin Transl Med
; 12(3): e772, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35297218